We are live on
!
Find out more
Voloridge Investment Management Portfolio holdings
AUM
$25B
1-Year Est. Return
28.08%
This Fund
S&P 500
This Quarter
Est. Return
+24.52%
1 Year Est. Return
+28.08%
3 Year Est. Return
+85.2%
5 Year Est. Return
+73.43%
10 Year Est. Return
+582.16%
AUM
$11.9B
AUM Growth
-$101M
(-0.84%)
Cap. Flow
-$1.72B
Cap. Flow
% of AUM
-14.47%
Top 10 Holdings %
Top 10 Hldgs %
16.8%
Holding
1,692
New
482
Increased
315
Reduced
482
Closed
413
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$242M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$187M |
| 3 |
AstraZeneca
AZN
|
+$163M |
| 4 |
Lockheed Martin
LMT
|
+$162M |
| 5 |
S&P Global
SPGI
|
+$125M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$234M |
| 2 |
Johnson & Johnson
JNJ
|
+$185M |
| 3 |
Mercado Libre
MELI
|
+$136M |
| 4 |
Procter & Gamble
PG
|
+$128M |
| 5 |
Shopify
SHOP
|
+$126M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.38% |
| 2 | Healthcare | 15.54% |
| 3 | Consumer Discretionary | 12.1% |
| 4 | Industrials | 11.12% |
| 5 | Communication Services | 10.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
Nordson
NDSN
$17.3B
| $229K | ﹤0.01% |
+1,138
| New | +$228K |
|
1252
Cullen/Frost Bankers
CFR
$10.4B
| $228K | ﹤0.01% |
2,612
-11,009
| -81% | -$865K |
|
1253
Anavex Life Sciences
AVXL
$316M
| $227K | ﹤0.01% |
+41,951
| New | +$221K |
|
1254
Reliance Steel & Aluminium
RS
$21.8B
| $227K | ﹤0.01% |
+1,895
| New | +$219K |
|
1255
Cimpress
CMPR
$2.4B
| $225K | ﹤0.01% |
+2,564
| New | +$220K |
|
|
ELME
1256
Elme Communities
ELME
$144M
| $224K | ﹤0.01% |
10,336
-31,992
| -76% | -$685K |
|
1257
Lowe's Companies
LOW
$121B
| $219K | ﹤0.01% |
+1,367
| New | +$222K |
|
1258
Sutro Biopharma
STRO
$353M
| $219K | ﹤0.01% |
+1,009
| New | +$167K |
|
1259
Logitech
LOGI
$14.8B
| $218K | ﹤0.01% |
2,245
-75,456
| -97% | -$6.51M |
|
1260
Telephone and Data Systems
TDS
$3.82B
| $218K | ﹤0.01% |
11,724
-2,962
| -20% | -$54.4K |
|
1261
Saic
SAIC
$5.34B
| $215K | ﹤0.01% |
+2,269
| New | +$199K |
|
1262
Archrock
AROC
$5.84B
| $213K | ﹤0.01% |
+24,593
| New | +$180K |
|
1263
MakeMyTrip
MMYT
$5.67B
| $213K | ﹤0.01% |
7,211
-63,365
| -90% | -$1.44M |
|
1264
Rhythm Pharmaceuticals
RYTM
$8.1B
| $213K | ﹤0.01% |
7,175
-29,794
| -81% | -$757K |
|
1265
Dorman Products
DORM
$3.97B
| $211K | ﹤0.01% |
+2,433
| New | +$226K |
|
1266
Arrow Electronics
ARW
$10.7B
| $207K | ﹤0.01% |
+2,124
| New | +$188K |
|
1267
Amkor Technology
AMKR
$13.8B
| $201K | ﹤0.01% |
+13,327
| New | +$182K |
|
|
AXON
1268
Axon Enterprise
AXON
$48.7B
| $200K | ﹤0.01% |
+1,635
| New | +$188K |
|
|
HIMX
1269
Himax Technologies
HIMX
$2.63B
| $196K | ﹤0.01% |
+26,538
| New | +$136K |
|
1270
A10 Networks
ATEN
$2B
| $181K | ﹤0.01% |
+18,312
| New | +$144K |
|
|
EXK
1271
Endeavour Silver
EXK
$3.14B
| $163K | ﹤0.01% |
+32,298
| New | +$119K |
|
1272
Urban Edge Properties
UE
$2.75B
| $152K | ﹤0.01% |
+11,783
| New | +$141K |
|
|
CIM
1273
Chimera Investment
CIM
$991M
| $147K | ﹤0.01% |
4,790
-51,202
| -91% | -$1.48M |
|
1274
NovaGold Resources
NG
$3.45B
| $147K | ﹤0.01% |
+15,218
| New | +$161K |
|
1275
Companhia Siderúrgica Nacional
SID
$1.15B
| $142K | ﹤0.01% |
+23,911
| New | +$102K |
|
Similar funds
VAI
Voloridge Investment Management's Q4 2020 Portfolio in Review
As of Q4 2020, Voloridge Investment Management held 1,692 positions worth $11.9B, down 0.84% from $12B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Voloridge Investment Management withdrew a net $1.72B in Q4 2020, closing 413 positions and reducing 482 holdings. Its most notable exit was Wells Fargo, an estimated $111M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Voloridge Investment Management opened a new position in AstraZeneca worth $154M.
- Voloridge Investment Management's largest Q4 2020 buy was AstraZeneca: 1,542,881 shares worth $154M.
- Voloridge Investment Management added most to Microsoft in Q4 2020, an estimated $242M increase.
- Voloridge Investment Management's biggest Q4 2020 reduction was Citigroup, cutting an estimated $234M.
- Voloridge Investment Management fully exited Wells Fargo in Q4 2020, selling an estimated $111M.
- Voloridge Investment Management's ten largest holdings make up 17% of its $11.9B portfolio in Q4 2020.
- Voloridge Investment Management opened 482 new positions and closed 413 in Q4 2020.
- Voloridge Investment Management's portfolio value fell 0.84% quarter-over-quarter to $11.9B.
Based on Voloridge Investment Management's 13F filing for Q4 2020, filed 16 Feb 2021.